284 related articles for article (PubMed ID: 18760363)
1. Emerging roles of J proteins in neurodegenerative disorders.
Gibbs SJ; Braun JE
Neurobiol Dis; 2008 Nov; 32(2):196-9. PubMed ID: 18760363
[TBL] [Abstract][Full Text] [Related]
2. Modulation of neurodegeneration by molecular chaperones.
Muchowski PJ; Wacker JL
Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
[TBL] [Abstract][Full Text] [Related]
3. Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK; Paul S
FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
[TBL] [Abstract][Full Text] [Related]
4. Polyglutamine diseases and molecular chaperones.
Kimura Y; Kakizuka A
IUBMB Life; 2003 Jun; 55(6):337-45. PubMed ID: 12938736
[TBL] [Abstract][Full Text] [Related]
5. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
[TBL] [Abstract][Full Text] [Related]
6. The role of heat shock proteins as chaperones on several human diseases.
Mellati AA
Saudi Med J; 2006 Sep; 27(9):1302-5. PubMed ID: 16951762
[TBL] [Abstract][Full Text] [Related]
7. Quality control against misfolded proteins in the cytosol: a network for cell survival.
Kubota H
J Biochem; 2009 Nov; 146(5):609-16. PubMed ID: 19737776
[TBL] [Abstract][Full Text] [Related]
8. Clusterin and Alzheimer's disease.
Calero M; Rostagno A; Frangione B; Ghiso J
Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
[TBL] [Abstract][Full Text] [Related]
9. Molecular chaperones as regulators of cell death.
Hishiya A; Takayama S
Oncogene; 2008 Oct; 27(50):6489-506. PubMed ID: 18955975
[TBL] [Abstract][Full Text] [Related]
10. The role of Hsp70 in age-related diseases and the prevention of cancer.
Pierpaoli EV
Ann N Y Acad Sci; 2005 Dec; 1057():206-19. PubMed ID: 16399896
[TBL] [Abstract][Full Text] [Related]
11. The role of molecular chaperones in human misfolding diseases.
Broadley SA; Hartl FU
FEBS Lett; 2009 Aug; 583(16):2647-53. PubMed ID: 19393652
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
Sloan LA; Fillmore MC; Churcher I
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic opportunities in polyglutamine disease.
Hughes RE; Olson JM
Nat Med; 2001 Apr; 7(4):419-23. PubMed ID: 11283667
[TBL] [Abstract][Full Text] [Related]
14. The intramolecular chaperone-mediated protein folding.
Chen YJ; Inouye M
Curr Opin Struct Biol; 2008 Dec; 18(6):765-70. PubMed ID: 18973809
[TBL] [Abstract][Full Text] [Related]
15. The attention of researchers on the biological process of protein folding has turned to the formation and properties of aggregates.
Ellis RJ
Semin Cell Dev Biol; 2004 Feb; 15(1):1-2. PubMed ID: 15036201
[No Abstract] [Full Text] [Related]
16. Chaperone-percolator model: a possible molecular mechanism of Anfinsen-cage-type chaperones.
Csermely P
Bioessays; 1999 Nov; 21(11):959-65. PubMed ID: 10517869
[TBL] [Abstract][Full Text] [Related]
17. Sick chaperones, cellular stress, and disease.
Macario AJ; Conway de Macario E
N Engl J Med; 2005 Oct; 353(14):1489-501. PubMed ID: 16207851
[No Abstract] [Full Text] [Related]
18. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
Muchowski PJ
Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
[TBL] [Abstract][Full Text] [Related]
19. From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery.
Meimaridou E; Gooljar SB; Chapple JP
J Mol Endocrinol; 2009 Jan; 42(1):1-9. PubMed ID: 18852216
[TBL] [Abstract][Full Text] [Related]
20. Stress proteins in CNS inflammation.
van Noort JM
J Pathol; 2008 Jan; 214(2):267-75. PubMed ID: 18161755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
